Schott Pharma AG KGaA (CHIX:1SXPD) Other Operating Expense : €-5.3 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA Other Operating Expense?

Schott Pharma AG KGaA's Other Operating Expense for the three months ended in Dec. 2024 was €1.2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-5.3 Mil.

Schott Pharma AG KGaA's quarterly Other Operating Expense declined from Jun. 2024 (€10.5 Mil) to Sep. 2024 (€-17.2 Mil) but then increased from Sep. 2024 (€-17.2 Mil) to Dec. 2024 (€1.2 Mil).

Schott Pharma AG KGaA's annual Other Operating Expense increased from Sep. 2022 (€-6.6 Mil) to Sep. 2023 (€-3.3 Mil) but then declined from Sep. 2023 (€-3.3 Mil) to Sep. 2024 (€-16.1 Mil).

Schott Pharma AG KGaA Other Operating Expense Historical Data

The historical data trend for Schott Pharma AG KGaA's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Other Operating Expense Chart

Schott Pharma AG KGaA Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Sep24

Other Operating Expense

-8.41

-3.38

-6.65

-3.35

-16.08

Schott Pharma AG KGaA Quarterly Data
	Sep20	Sep21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial							-9.58	0.17	10.51	-17.18	1.19

Schott Pharma AG KGaA Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-5.3 Mil.

Schott Pharma AG KGaA Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

SHTPY:USA 1SXP:Italy 1SXP:Germany 1SXP:Austria

Address

Hattenbergstrasse 10, Mainz, RP, DEU, 55122

Website

https://www.schott-pharma.com

Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines